June 28, 2022

News

News Network

St. Jude Agrees to Pay $27 Million for Allegedly Selling Defective Heart Devices

1 min read
<div>St. Jude Medical Inc. (St. Jude) has agreed to pay $27 million to settle allegations under the False Claims Act that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal health care programs. St. Jude was acquired by Abbott Laboratories in January 2017.</div>
St. Jude Medical Inc. (St. Jude) has agreed to pay $27 million to settle allegations under the False Claims Act that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal health care programs. St. Jude was acquired by Abbott Laboratories in January 2017.

More from: July 8, 2021

Crime ACN News Network

Network News © 2005 Area.Control.Network™ All rights reserved.
All Rights Reserved © ACN 2020

ACN Privacy Policies
ACN TOS
Area Control Network (ACN)
Area Control Network
Area Control Network Center